Baader Bank Reiterates €24.00 Price Target for Rhoen Klinikum AG (RHK)
Other research analysts have also issued research reports about the company. Berenberg Bank set a €26.00 ($30.23) target price on Rhoen Klinikum AG and gave the company a neutral rating in a report on Tuesday, August 1st. Deutsche Bank AG set a €21.00 ($24.42) target price on Rhoen Klinikum AG and gave the company a neutral rating in a report on Wednesday, July 26th. Commerzbank Ag set a €25.00 ($29.07) target price on Rhoen Klinikum AG and gave the company a neutral rating in a report on Tuesday, July 25th. Warburg Research set a €26.00 ($30.23) target price on Rhoen Klinikum AG and gave the company a neutral rating in a report on Thursday, August 3rd. Finally, Independent Research GmbH set a €28.00 ($32.56) target price on Rhoen Klinikum AG and gave the company a neutral rating in a report on Monday, August 14th. Four equities research analysts have rated the stock with a sell rating and six have issued a hold rating to the company’s stock. Rhoen Klinikum AG currently has a consensus rating of Hold and a consensus price target of €24.49 ($28.48).
Rhoen Klinikum AG (ETR RHK) opened at €30.15 ($35.06) on Friday. Rhoen Klinikum AG has a twelve month low of €22.66 ($26.35) and a twelve month high of €30.65 ($35.64).
COPYRIGHT VIOLATION WARNING: This report was originally reported by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another publication, it was illegally copied and reposted in violation of United States & international trademark & copyright laws. The legal version of this report can be viewed at https://www.watchlistnews.com/baader-bank-reiterates-24-00-price-target-for-rhoen-klinikum-ag-rhk/1699595.html.
Rhoen Klinikum AG Company Profile
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases.
Receive News & Ratings for Rhoen Klinikum AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum AG and related companies with Analyst Ratings Network's FREE daily email newsletter.